Dual Inhibition of CDK12/CDK13 Targets Both Tumor and Immune Cells in Ovarian CancerLin Cheng(Shanghai Jiao Tong University), Li Tan(Shanghai Institute of Organic Chemistry)Cancer ResearchJuly 20, 202210.1158/0008-5472.can-22-0222Cited by 55SaveCiteExport RISWatch citationsRelated PapersDevelopment of Selective Covalent Janus Kinase 3 Inhibitors|Journal of Medicinal Chemistry|2015|115Pseudolaric acid B attenuates atopic dermatitis-like skin lesions by inhibiting interleukin-17-induced inflammation|Scientific Reports|2017|19